Transcatheter aortic valve replacement (TAVR) was more costly upfront than surgical AVR (SAVR), but total 2-year costs were about $2000 lower in low-surgical risk patients with severe aortic stenosis in the pivotal PARTNER 3 trial, new research shows. TAVR was projected to be a “highly cost-effective” therapy over a lifetime compared with SAVR, assuming no major […]

Delirium is more common in patients undergoing transcatheter rather than surgical aortic valve replacement (TAVR, SAVR) but predicted worse in-hospital outcomes after both procedures, a new study suggests. “Patients experience delirium fairly frequently after aortic valve replacement, whether transcatheter or surgical, but we found that it happens more often after surgical replacement,” coauthor Amar Krishnaswamy, […]